P
Patty M. Jansen
Researcher at Leiden University Medical Center
Publications - 66
Citations - 3771
Patty M. Jansen is an academic researcher from Leiden University Medical Center. The author has contributed to research in topics: Lymphoma & Mycosis fungoides. The author has an hindex of 27, co-authored 61 publications receiving 3346 citations. Previous affiliations of Patty M. Jansen include Leiden University & Columbia University.
Papers
More filters
Journal ArticleDOI
Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases.
Rein Willemze,Patty M. Jansen,Lorenzo Cerroni,Emilio Berti,Marco Santucci,Chalid Assaf,Marijke R. Canninga-van Dijk,Agnes Carlotti,M.L. Geerts,Sonja Hahtola,Michael Hummel,Leila Jeskanen,Werner Kempf,Cesare Massone,Pablo L. Ortiz-Romero,Marco Paulli,Tony Petrella,Annamari Ranki,José L. Rodriguez Peralto,Alistair Robson,Nancy J. Senff,Maarten H. Vermeer,Janine Wechsler,Sean Whittaker,Chris J.L.M. Meijer +24 more
TL;DR: SPTL-ABs without associated HPS have an excellent prognosis, and multiagent chemotherapy as first choice of treatment should be questioned, while SPTL-GDs often showed (epi)dermal involvement and/or ulceration, a CD4-, CD8-, CD56+/-, betaF1- T-cell phenotype, and poor prognosis (5-year OS: 11%), irrespective of the presence of HPS or type of treatment.
Journal ArticleDOI
Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling
Juliette J. Hoefnagel,Remco Dijkman,Remco Dijkman,Katia Basso,Katia Basso,Patty M. Jansen,Patty M. Jansen,Christian Hallermann,Christian Hallermann,Rein Willemze,Rein Willemze,Cornelis P. Tensen,Cornelis P. Tensen,Maarten H. Vermeer,Maarten H. Vermeer +14 more
TL;DR: It is suggested that different pathogenetic mechanisms are involved in the development of PCFCCLs and PCLBCLs-leg and provide molecular support for the subdivision used in the EORTC classification.
Journal ArticleDOI
Reclassification of 300 Primary Cutaneous B-Cell Lymphomas According to the New WHO–EORTC Classification for Cutaneous Lymphomas: Comparison With Previous Classifications and Identification of Prognostic Markers
Nancy J. Senff,Juliette J. Hoefnagel,Patty M. Jansen,Maarten H. Vermeer,Joop van Baarlen,Willeke A. M. Blokx,Marijke R. Canninga-van Dijk,M.L. Geerts,Konnie M. Hebeda,Philip M. Kluin,King H. Lam,Chris J.L.M. Meijer,Rein Willemze +12 more
TL;DR: The results emphasize the clinical significance of the WHO-EORTC classification, but suggest that within the group of PCFCL, distinction should be made between lymphomas presenting on the legs and lymphomasPresenting at other sites.
Journal ArticleDOI
Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients.
Marcel W. Bekkenk,Maarten H. Vermeer,Patty M. Jansen,Ariënne M W van Marion,Marijke R. Canninga-van Dijk,Philip M. Kluin,M.L. Geerts,Chris J.L.M. Meijer,Rein Willemze +8 more
TL;DR: The results indicate that peripheral T-cell lymphomas, unspecified, presenting in the skin have an unfavorable prognosis, irrespective of the presence or absence of extracutaneous disease at the time of diagnosis, cell size, and expression of a CD4+ or CD8+ phenotype.
Journal ArticleDOI
CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature
TL;DR: The striking similarities between blastic NK-cell lymphomas and CD56+ myeloid leukemias presenting in the skin provide a rationale to treat these patients with more aggressive regimens, rather than with CHOP(-like) regimens and radiotherapy, which have proven to be inadequate therapies for this neoplasm.